approved

Приложение 4 на ПЛС от 02.09.2019 г.

Unique identificator:  1b2fb502-1864-49cb-8754-bf8d6a3c8537

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-09-03 10:33:17
  • Created by: georgi_sivchev
  • Updated at: 2019-09-03 10:33:17
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.72 0.74 4.46 7% 0.26 3.98 0.8 4.78 20% 0.74 4.72 0.94 5.66 НСР-5738/26.02.2015. 12.03.2015 12.03.2015 Неактивен 3635
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.91 0.78 4.69 7% 0.27 4.18 0.84 5.02 20% 0.78 4.96 0.99 5.95 КЦРР-1205/13.08.2012 г 28.12.2012 28.12.2012 Неактивен 3635
Somatostatin II-0860/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 89.58 17.92 107.5 4% 3.58 93.16 18.63 111.79 16% 14.33 107.49 21.5 128.99 КЦ-673/06.03.2009 24.03.2009 24.03.2009 Неактивен 1498
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 18.66 3.73 22.39 6% 1.12 19.78 3.96 23.74 18% 3.36 23.14 4.63 27.77 КЦ-673/06.03.2009 24.03.2009 24.03.2009 Неактивен 3635
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3238.78 647.76 3886.54 4% 10 3248.78 649.76 3898.54 16% 25 3273.78 654.76 3928.54 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016.; НСР-17510/13.12.2018 28.12.2018 02.01.2019 Активен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016. 30.04.2016 02.12.2018 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 Протокол №242/14.09.2017 НСР-8981/14.04.2016. 30.04.2016 02.10.2017 Неактивен 3300
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение 25.06.2018 02.12.2018 Активен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение 25.06.2018 02.08.2018 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение* 25.06.2018 02.07.2018 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 Протокол №242/14.09.2017 НСР-8982/14.04.2016. 30.04.2016 02.10.2017 Неактивен 3301
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 6919.96 1383.99 8303.95 4% 10 6929.96 1385.99 8315.95 16% 25 6954.96 1390.99 8345.95 цената се заличава КЦРР-2538/14.03.2013 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Заличен 1643
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 7132.23 1426.45 8558.68 4% 10 7142.23 1428.45 8570.68 16% 25 7167.23 1433.45 8600.68 изготвено корекционно решение КЦ-670/06.03.2009 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 1643
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 НСР-8982/14.04.2016. 30.04.2016 30.04.2016 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4902.09 980.42 5882.51 4% 10 4912.09 982.42 5894.51 16% 25 4937.09 987.42 5924.51 Прот. № 136/16.09.2015 НСР-6850/30.07.2015 14.08.2015 14.08.2015 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5062.69 1012.54 6075.23 4% 10 5072.69 1014.54 6087.23 16% 25 5097.69 1019.54 6117.23 НСР-4867/17.10.2014 03.11.2014 03.11.2014 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5121.16 1024.23 6145.39 4% 10 5131.16 1026.23 6157.39 16% 25 5156.16 1031.23 6187.39 НСР-2338/13.01.2014 28.01.2014 28.01.2014 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5265.64 1053.13 6318.77 4% 10 5275.64 1055.13 6330.77 16% 25 5300.64 1060.13 6360.77 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5349.2 1069.84 6419.04 4% 10 5359.2 1071.84 6431.04 16% 25 5384.2 1076.84 6461.04 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 3301
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 НСР-8981/14.04.2016. 30.04.2016 30.04.2016 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3266.02 653.2 3919.22 4% 10 3276.02 655.2 3931.22 16% 25 3301.02 660.2 3961.22 Прот. № 136/16.09.2015 НСР-6849/30.07.2015 14.08.2015 14.08.2015 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3383.76 676.75 4060.51 4% 10 3393.76 678.75 4072.51 16% 25 3418.76 683.75 4102.51 НСР-4868/17.10.2014 03.11.2014 03.11.2014 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3420.26 684.05 4104.31 4% 10 3430.26 686.05 4116.31 16% 25 3455.26 691.05 4146.31 НСР-2338/13.01.2014 28.01.2014 28.01.2014 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3459.98 692 4151.98 4% 10 3469.98 694 4163.98 16% 25 3494.98 699 4193.98 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3566.1 713.22 4279.32 4% 10 3576.1 715.22 4291.32 16% 25 3601.1 720.22 4321.32 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 3300
Showing 12776 to 12801 of 15886 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте